Advanced Enzyme Technologies Ltd - 540025 - Corporate Action-Board approves Dividend
The Board of Directors of the Company, Recommended a Final Dividend @55% i.e. 1.1 /- per Equity share on the face value ?2 /- each for the financial year 2023-24, subject to the approval of the Shareholders at the ensuing 35th Annual General Meeting of the Company Advanced Enzyme Technologies Ltd - 540025 - Board Meeting Outcome for The Company Has Informed The Exchange About The Outcome Of The Board Meeting Held On May 11, 2024; 1) Financial Results 2) Final Dividend 3) Interim Dividend
The Company has informed the Exchange about the Outcome of the Board Meeting held on May 11, 2024; 1) Financial Results 2) Final Dividend 3) Interim Dividend Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the Financial results of the Company for the quarter and year ended March 31, 2024 on Wednesday, May 15, 2024 at 04:00 p.m. (IST) as per the details provided in the Attachment Advanced Enzyme Technologies Ltd - 540025 - Board Meeting Intimation for Intimation Of Board Meeting, Record Date For Interim Dividend, If Declared By The Board And Closure Of Trading Window
Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2024 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 11, 2024, inter alia, to consider the following: To consider & approve annual Financial Statements (Standalone & Consolidated) of the Company for the financial year ended March 31, 2024 along with results of the fourth quarter; To consider & recommend Final dividend, if any, for the financial year ended March 31, 2024, and/or to consider & declare Interim Dividend, if any for the financial year ended March 31, 2025. The Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY2024-25, if any declared by the Board of Directors of the Company shall be Saturday, May 18, 2024. Closure of Trading Window: Further to our letter dated March 29, 2024 intimating closure of Trading Window, we wish to inform you that the 'Trading Window' for dealing in the Securities of the Company will continue to remain closed up to May 13, 2024 Advanced Enzyme Technologies Ltd - 540025 - Intimation Of Record Date For Interim Dividend, If Any, Declared By The Board
This is to inform you that, a meeting of Board of Directors of the Company is scheduled to be held on Saturday May 11, 2024 inter-alia to consider & recommend Final Dividend , if any, for the financial year ended March 31, 2024, and/or to consider & declare Interim Dividend , if any for the financial year ended March 31, 2025. The Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY 2024-25, if any declared by the Board of Directors of the Company shall be Saturday, May 18, 2024 Advanced Enzyme Technologies Ltd - 540025 - Intimation Of Board Meeting, Record Date For Interim Dividend, If Declared By The Board And Closure Of Trading Window
This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 11, 2024 inter-alia to consider the following: (i) to consider & approve annual financial statements (Standalone and consolidated) of the Company for financial year ended March 31, 2024 along with results of the fourth quarter; (ii) to consider & recommend Final Dividend if any for the financial year ended March 31, 2024 and/or consider and declare Interim Dividend if any, for the financial year ended March 31, 2025. Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY 2024-25, if any declared by the Board of Directors of the Company shall be Saturday, May 18, 2024 Advanced Enzyme Technologies Ltd - 540025 - Compliance Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2024
Pursuant to Regulations 40(9) of Securities and Exchange Board of India (Lisiting Obligations and Disclosure Requirements) Regulations, 2015 (as amended) enclosed is a Certificate dated April 19, 2024 from Ms. Riddhi Shah, Practising Company Secretary, for the financial year ended March 31, 2024. Advanced Enzyme Technologies Ltd - 540025 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAdvanced Enzyme Technologies Ltd 2CIN NO.L24200MH1989PLC051018 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY A+Stable 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sanjay Basantani Designation: Company Secretary and Head Legal EmailId: [email protected] Name of the Chief Financial Officer: Beni Prasad Rauka Designation: Chief Financial Officer EmailId: [email protected] Date: 17/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Advanced Enzyme Technologies Ltd - 540025 - Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015